These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37167277)

  • 1. Older patient age and prior antimicrobial use strongly predict antimicrobial resistance in Escherichia coli isolates recovered from urinary tract infections among female outpatients.
    Mitrani-Gold FS; Kaye KS; Gupta V; Mulgirigama A; Trautner BW; Scangarella-Oman NE; Yu KC; Ye G; Joshi AV
    PLoS One; 2023; 18(5):e0285427. PubMed ID: 37167277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management.
    Kaye KS; Gupta V; Mulgirigama A; Joshi AV; Scangarella-Oman NE; Yu K; Ye G; Mitrani-Gold FS
    Clin Infect Dis; 2021 Dec; 73(11):1992-1999. PubMed ID: 34143881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020.
    Dunne MW; Aronin SI; Yu KC; Watts JA; Gupta V
    BMC Infect Dis; 2022 Feb; 22(1):194. PubMed ID: 35227203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients].
    Marković T; Jeinić L; Smitran A; Petković M
    Srp Arh Celok Lek; 2013; 141(11-12):775-9. PubMed ID: 24502096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-resistance Among Escherichia coli and Klebsiella pneumoniae Urine Isolates from Female Outpatients with Presumed UTI: A Retrospective US Cohort Study.
    Kaye KS; Gupta V; Mulgirigama A; Joshi AV; Scangarella-Oman NE; Yu K; Watts J; Mitrani-Gold FS
    Infect Dis Ther; 2024 Jul; 13(7):1715-1722. PubMed ID: 38842759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, regional distribution, and trends of antimicrobial resistance among female outpatients with urine Klebsiella spp. isolates: a multicenter evaluation in the United States between 2011 and 2019.
    Kaye KS; Gupta V; Mulgirigama A; Joshi AV; Ye G; Scangarella-Oman NE; Yu K; Mitrani-Gold FS
    Antimicrob Resist Infect Control; 2024 Feb; 13(1):21. PubMed ID: 38355621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Resistance in Bacteria Causing Urinary Tract Infections.
    Salh KK
    Comb Chem High Throughput Screen; 2022; 25(7):1219-1229. PubMed ID: 34161207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence and Genomic Characterization of Clone ST1193 Clonotype 14-64 in Uncomplicated Urinary Tract Infections Caused by Escherichia coli in Spain.
    García-Meniño I; Lumbreras P; Lestón L; Álvarez-Álvarez M; García V; Hammerl JA; Fernández J; Mora A
    Microbiol Spectr; 2022 Jun; 10(3):e0004122. PubMed ID: 35604206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmidic Fluoroquinolone Resistance Genes in Fluoroquinolone-Resistant and/or Extended Spectrum Beta-Lactamase-Producing
    Akgoz M; Akman I; Ates AB; Celik C; Keskin B; Ozmen Capin BB; Karahan ZC
    Microb Drug Resist; 2020 Nov; 26(11):1334-1341. PubMed ID: 32407158
    [No Abstract]   [Full Text] [Related]  

  • 12. High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli.
    Rattanaumpawan P; Nachamkin I; Bilker WB; Roy JA; Metlay JP; Zaoutis TE; Lautenbach E;
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):25. PubMed ID: 28390438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018-2020.
    Faine BA; Rech MA; Vakkalanka P; Gross A; Brown C; Harding SJ; Slocum G; Zimmerman D; Zepeski A; Rewitzer S; Howington GT; Campbell M; Dawson J; Treu CN; Nelson L; Jones M; Flack T; Porter B; Sarangarm P; Mattson AE; Bailey A; Kelly G; Talan DA
    Acad Emerg Med; 2022 Sep; 29(9):1096-1105. PubMed ID: 35652493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.
    Colpan A; Johnston B; Porter S; Clabots C; Anway R; Thao L; Kuskowski MA; Tchesnokova V; Sokurenko EV; Johnson JR;
    Clin Infect Dis; 2013 Nov; 57(9):1256-65. PubMed ID: 23926176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
    Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z
    Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
    Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
    World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Class 1 Integrons and Extended Spectrum Beta Lactamases among Multi-Drug Resistant Escherichia coli Isolates from North of Iran.
    Mehdipour Moghaddam MJ; Mirbagheri AA; Salehi Z; Habibzade SM
    Iran Biomed J; 2015; 19(4):233-9. PubMed ID: 26220727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the Prevalence of Antimicrobial Resistance in Escherichia coli Isolated from Outpatient Urine Cultures in French Amazonia.
    Nkontcho Djamkeba F; Sainte-Rose V; Lontsi Ngoulla GR; Roujansky A; Abboud P; Walter G; Houcke S; Demar M; Kallel H; Pujo JM; Djossou F
    Am J Trop Med Hyg; 2024 Aug; 111(2):287-296. PubMed ID: 38917783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Prevalence of Multidrug-Resistant Escherichia coli in Urine Samples from Inpatients and Outpatients at a Tertiary Care Hospital in Sétif, Algeria.
    Nabti LZ; Sahli F; Radji N; Mezaghcha W; Semara L; Aberkane S; Lounnas M; Solassol J; Didelot MN; Jean-Pierre H; Dumont Y; Godreuil S
    Microb Drug Resist; 2019 Apr; 25(3):386-393. PubMed ID: 30676258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study.
    Aypak C; Altunsoy A; Düzgün N
    Ann Clin Microbiol Antimicrob; 2009 Oct; 8():27. PubMed ID: 19852849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.